These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26686637)

  • 21. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
    Ko KW; Milbrandt J; DiAntonio A
    J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SARM1 axon degeneration pathway: control of the NAD
    Figley MD; DiAntonio A
    Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
    Gerdts J; Summers DW; Milbrandt J; DiAntonio A
    Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.
    Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A
    Elife; 2017 Jan; 6():. PubMed ID: 28095293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.
    White MA; Lin Z; Kim E; Henstridge CM; Pena Altamira E; Hunt CK; Burchill E; Callaghan I; Loreto A; Brown-Wright H; Mead R; Simmons C; Cash D; Coleman MP; Sreedharan J
    Acta Neuropathol Commun; 2019 Oct; 7(1):166. PubMed ID: 31661035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly.
    Neukomm LJ; Burdett TC; Seeds AM; Hampel S; Coutinho-Budd JC; Farley JE; Wong J; Karadeniz YB; Osterloh JM; Sheehan AE; Freeman MR
    Neuron; 2017 Jul; 95(1):78-91.e5. PubMed ID: 28683272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
    Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
    Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARM1 can be a potential therapeutic target for spinal cord injury.
    Lu Q; Botchway BOA; Zhang Y; Jin T; Liu X
    Cell Mol Life Sci; 2022 Feb; 79(3):161. PubMed ID: 35224705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological bypass of NAD
    Liu HW; Smith CB; Schmidt MS; Cambronne XA; Cohen MS; Migaud ME; Brenner C; Goodman RH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10654-10659. PubMed ID: 30257945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An NAD+/NMN balancing act by SARM1 and NMNAT2 controls axonal degeneration.
    Waller TJ; Collins CA
    Neuron; 2021 Apr; 109(7):1067-1069. PubMed ID: 33831359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of initiation and regulation of axonal degeneration with special reference to NMNATs and Sarm1.
    Funakoshi M; Araki T
    Neurosci Res; 2023 Dec; 197():3-8. PubMed ID: 34767875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
    Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
    Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase transition reduces the threshold for nicotinamide mononucleotide-based activation of SARM1, an NAD(P) hydrolase, to physiologically relevant levels.
    Icso JD; Thompson PR
    J Biol Chem; 2023 Nov; 299(11):105284. PubMed ID: 37742918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
    Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
    Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conformation-specific nanobody targeting the nicotinamide mononucleotide-activated state of SARM1.
    Hou YN; Cai Y; Li WH; He WM; Zhao ZY; Zhu WJ; Wang Q; Mai X; Liu J; Lee HC; Stjepanovic G; Zhang H; Zhao YJ
    Nat Commun; 2022 Dec; 13(1):7898. PubMed ID: 36550129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy.
    Turkiew E; Falconer D; Reed N; Höke A
    J Peripher Nerv Syst; 2017 Sep; 22(3):162-171. PubMed ID: 28485482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NAD
    Alexandris AS; Koliatsos VE
    Antioxid Redox Signal; 2023 Dec; 39(16-18):1167-1184. PubMed ID: 37503611
    [No Abstract]   [Full Text] [Related]  

  • 39. The mitochondrial Nod-like receptor NLRX1 modifies apoptosis through SARM1.
    Killackey SA; Rahman MA; Soares F; Zhang AB; Abdel-Nour M; Philpott DJ; Girardin SE
    Mol Cell Biochem; 2019 Mar; 453(1-2):187-196. PubMed ID: 30191480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of degenerative spheroids after injury.
    Yong Y; Gamage K; Cushman C; Spano A; Deppmann C
    Sci Rep; 2020 Sep; 10(1):15472. PubMed ID: 32963272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.